Cited by 6,471Cancer Genomics and DiagnosticsCancer Cells and MetastasisEvolution and Genetic Dynamics

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Nowell, Peter C.·1976·Science

Open this paper in CoChat — free account

Abstract

It is proposed that most neoplasms arise from a single cell of origin, and tumor progression results from acquired genetic variability within the original clone allowing sequential selection of more aggressive sublines. Tumor cell populations are apparently more genetically unstable than normal cells, perhaps from activation of specific gene loci in the neoplasm, continued presence of carcinogen, or even nutritional deficiencies within the tumor. The acquired genetic insta0ility and associated selection process, most readily recognized cytogenetically, results in advanced human malignancies being highly individual karyotypically and biologically. Hence, each patient's cancer may require individual specific therapy, and even this may be thwarted by emergence of a genetically variant subline resistant to the treatment. More research should be directed toward understanding and controlling the evolutionary process in tumors before it reaches the late stage usually seen in clinical cancer.

Integrity signals

Registry

Crossref · 10.1126/science.959840

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,592
Normal genetically mosaic mice produced from malignant teratocarcinoma cells.
Mintz, B., & Illmensee, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3585 · Cited by 1,179
Handbuch der allgemeinen pathologie
(1973) · Experimental Gerontology · doi:10.1016/0531-5565(73)90021-1 · Cited by 794
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
Linder, D., & Gartler, S. M. (1965) · Science · doi:10.1126/science.150.3692.67 · Cited by 398
Differentiation of malignant to benign cells
Kauffman, S. A. (1971) · Journal of Theoretical Biology · doi:10.1016/0022-5193(71)90020-8 · Cited by 309
Suppression of malignancy in human cells
Stanbridge, E. J. (1976) · Nature · doi:10.1038/260017a0 · Cited by 307
Methodology in mammalian genetics
Burdette, W. J. (1963) · Holden-Day eBooks · doi:10.5962/bhl.title.6428 · Cited by 302
Chromosomes and cancer
LEVAN, A., Levan, G., & Mitelman, F. (2009) · Hereditas · doi:10.1111/j.1601-5223.1977.tb01208.x · Cited by 263
The analysis of malignancy by cell fusion: I. hybrids between tumour cells and l cell derivatives
Klein, G., Bregula, U., Wiener, F., & Harris, H. (1971) · Journal of Cell Science · doi:10.1242/jcs.8.3.659 · Cited by 248
Neoplasia: a disease of cell differentiation.
Markert, C. L. (1968) · PubMed · Cited by 244

Flagged first, then by citations

Show all 52 references

1 of the 52 references couldn’t be matched to a known paper.

Research works printed but not linked: 24

ALSAADI, A, SEQUENTIAL CYTOGENETIC CHANGES IN EVOLUTION OFTRANSPLANTED THYROID TUMORS IN METASTATIC CARCINOMA IN FICHER RAT, CANCER RESEARCH 27: 1831 (1967).
BOYSE, E.A., CURRENT RES ONCOLOGY: 57 (1972).
DIPAOLO, J.A., KARYOLOGICAL INSTABILITY OF NEOPLASTIC SOMATIC-CELLS, IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION 11: 89 (1975).
FOLKMAN, J, S FUNDAMENTAL ASPECT: 331 (1975).
FURTH, J, NATIONAL CANCER INSTITUTE MONOGRAPHS 2: 148 (1960).
GERMAN, J, GENES WHICH INCREASE CHROMOSOMAL INSTABILITY IN SOMATIC CELLS AND PREDISPOSE TO CANCER, PROGRESS IN MEDICAL GENETICS 8: 61 (1972).
GOLUB, S.H., CANCER COMPREHENSIVE 4: 259 (1975).
GROUCHY, J.D., CHROMOSOMES CANCER: 287 (1974).
HANDEN, D.G., CHROMOSOMES CANCER: 151 (1974).
KLEIN, G, METHODOLOGY MAMMALIA: 407 (1963).
KNUDSON, A.G., HEREDITY AND CANCER IN MAN, PROGRESS IN MEDICAL GENETICS 9: 113 (1973).
MAKINO, S, ANN N Y ACAD SCI 64: 818 (1956).
Miller, E. C., The Molecular Biology of Cancer: 377 (1974).
NOWELL, P.C., CANCER COMPREHENSIVE 1: 3 (1975).
NOWELL, P.C., CHROMOSOMES CANCER J: 267 (1974).
ODELL, W, TXB ENDOCRINOLOGY: 1105 (1974).
Oksala, T., Chromosomes and Cancer: 239 (1974).
Pedersen, B., Proceedings of the Fourth International Congress on Human Genetics: 166 (1972).
Pitot, H. C., Molecular Biology of Cancer: 523 (1974).
Robbins, J. C., Cancer: A Comprehensive Treatise 4: 3 (1975).
RUBIN, H, SCIENCE 191: 241 (1976). · DOI
STICH, H.F., CANADIAN CANCER CONFERENCE 5: 99 (1963).
WOLMAN, S.R., CANCER COMPREHENSIVE 3: 155 (1975).
Yosida, T. H., Handbuch der Allgemeinen Pathologic: 677 (1975).

Sorted by citations

Items 601–700 of 1,016

Chromosomal Imbalances in Barrett's Adenocarcinoma and the Metaplasia-Dysplasia-Carcinoma Sequence
Walch, A. K., Zitzelsberger, H. F., Bruch, J., Keller, G., Angermeier, D., Aubele, M. M., Mueller, J., Stein, H. J., Braselmann, H., Siewert, J. R., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64760-8 · Cited by 161
High levels of chromosome instability in polyploids of Saccharomyces cerevisiae
Mayer, V. W., & Aguilera, A. (1990) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(90)90024-x · Cited by 160
Histocompatibility Antigens on Murine Tumors
Goodenow, R. S., Vogel, J. M., & Linsk, R. (1985) · Science · doi:10.1126/science.2997918 · Cited by 160
Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancer
Archetti, M., Ferraro, D. A., & Christofori, G. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414653112 · Cited by 154
Heparanase and the hallmarks of cancer
Jayatilleke, K. M., & Hulett, M. D. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02624-1 · Cited by 167
RB: mitotic implications of a tumour suppressor
Manning, A. L., & Dyson, N. J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3216 · Cited by 160
Extensive genetic variation in somatic human tissues
O’Huallachain, M., Karczewski, K. J., Weissman, S. M., Urban, A. E., & Snyder, M. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1213736109 · Cited by 156
Hypomethylation: One Side of a Larger Picture
Dunn, B. K. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05960.x · Cited by 160
Social interaction in synthetic and natural microbial communities
Xavier, J. B. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.16 · Cited by 164
Expression of an Exogenous Human Oct-4 Promoter Identifies Tumor-Initiating Cells in Osteosarcoma
Levings, P. P., McGarry, S. V., Currie, T. P., Nickerson, D. M., McClellan, S. B., Ghivizzani, S. C., Steindler, D. A., & Gibbs, C. P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3580 · Cited by 162
Tracking Cancer Evolution through the Disease Course
Bailey, C., Black, J. R., Reading, J. L., Litchfield, K., Turajlic, S., McGranahan, N., Jamal‐Hanjani, M., & Swanton, C. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1559 · Cited by 159
The new stem cell biology: something for everyone
Preston, S. L., Alison, M. R., Forbes, S. J., Direkze, N. C., Poulsom, R., & Wright, N. A. (2003) · Molecular Pathology · doi:10.1136/mp.56.2.86 · Cited by 158
A Virus Causes Cancer by Inducing Massive Chromosomal Instability through Cell Fusion
Duelli, D. M., Padilla‐Nash, H. M., Berman, D. M., Murphy, K. M., Ried, T., & Lazebnik, Y. A. (2007) · Current Biology · doi:10.1016/j.cub.2007.01.049 · Cited by 160
Asymmetric cancer cell division regulated by AKT
Dey‐Guha, I., Wolfer, A., Yeh, A. C., Albeck, J. G., Darp, R., Leon, E., Wulfkuhle, J. D., Petricoin, E. F., Wittner, B. S., & Ramaswamy, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109632108 · Cited by 157
Between-region genetic divergence reflects the mode and tempo of tumor evolution
Sun, R., Hu, Z., Sottoriva, A., Graham, T. A., Harpak, A., Ma, Z., Fischer, J. M., Shibata, D. K., & Curtis, C. N. (2017) · Nature Genetics · doi:10.1038/ng.3891 · Cited by 151
Metastasis suppressor pathways—an evolving paradigm
Shevde, L. A., & Welch, D. R. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00304-5 · Cited by 157
Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival
Pai, V. P., Marshall, A. M., Hernandez, L. L., Buckley, A. R., & Horseman, N. D. (2009) · Breast Cancer Research · doi:10.1186/bcr2448 · Cited by 155
Heralding a new paradigm in 3D tumor modeling
Fong, E. L. S., Harrington, D. A., Farach‐Carson, M. C., & Yu, H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.052 · Cited by 156
SiFit: inferring tumor trees from single-cell sequencing data under finite-sites models
Zafar, H., Tzen, A., Navin, N. E., Chen, K., & Nakhleh, L. K. (2017) · Genome biology · doi:10.1186/s13059-017-1311-2 · Cited by 156
Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)
Horsman, D. E., Connors, J. M., Pantzar, T., & Gascoyne, R. D. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1103 · Cited by 156
Chromosome rearrangements resulting from telomere dysfunction and their role in cancer
Murnane, J. P., & Sabatier, L. (2004) · BioEssays · doi:10.1002/bies.20125 · Cited by 165
K-ras mutation and pancreatic adenocarcinoma
Caldas, C., & Kern, S. E. (1995) · International Journal of Pancreatology · doi:10.1007/bf02825415 · Cited by 156
Inferring clonal expansion and cancer stem cell dynamics from DNA methylation patterns in colorectal cancers
Siegmund, K. D., Marjoram, P., Woo, Y., Tavaré, S., & Shibata, D. K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810276106 · Cited by 155
The Odontogenic Keratocyst
Li, T. (2011) · Journal of Dental Research · doi:10.1177/0022034510379016 · Cited by 155
Mechanisms that drive inflammatory tumor microenvironment, tumor heterogeneity, and metastatic progression
Yang, H. H., & Lin, P. C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.001 · Cited by 157
Glycosidases in cancer and invasion
Bernacki, R. J., Niedbala, M. J., & Korytnyk, W. (1985) · Cancer and Metastasis Reviews · doi:10.1007/bf00047738 · Cited by 155
Persistently elevated frequency of spontaneous mutations in progeny of CHO clones surviving X-irradiation: association with delayed reproductive death phenotype
Chang, W. P., & Little, J. B. (1992) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(92)90130-t · Cited by 155
3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments
Albritton, J. L., & Miller, J. S. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.025049 · Cited by 154
Intratumor Heterogeneity in Breast Cancer
de Beça, F. F., & Polyák, K. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22909-6_7 · Cited by 160
Metabolic Adaptations in Cancer Stem Cells
Yadav, U. P., Singh, T., Kumar, P., Sharma, P., Kaur, H., Sharma, S., Singh, S., Kumar, S., & Mehta, K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01010 · Cited by 158
Regulatory T cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine
Kumagai, S., Itahashi, K., & Nishikawa, H. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00870-6 · Cited by 171
Genetic reconstruction of individual colorectal tumor histories
Tsao, J., Yatabe, Y., Salovaara, R., Järvinen, H., Mecklin, J., Aaltonen, L. A., Tavaré, S., & Shibata, D. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1236 · Cited by 149
The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis.
Fishel, R. A. (2001) · PubMed · Cited by 153
A Comprehensive Survey of Clonal Diversity Measures in Barrett's Esophagus as Biomarkers of Progression to Esophageal Adenocarcinoma
Merlo, L. M. F., Shah, N. A., Li, X., Blount, P. L., Vaughan, T. L., Reid, B. J., & Maley, C. C. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0108 · Cited by 153
Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer
Ricordel, C., Friboulet, L., Facchinetti, F., & Soria, J. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx705 · Cited by 156
Metastatic Potential
Hynes, R. O. (2003) · Cell · doi:10.1016/s0092-8674(03)00468-9 · Cited by 152
Advances in understanding tumour evolution through single-cell sequencing
Kuipers, J., Jahn, K., & Beerenwinkel, N. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.02.001 · Cited by 148
Steroidogenic acute regulatory (StAR) protein: what's new?
Stocco, D. M. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199909)21:9 · Cited by 47
Nutritional assessment and patient outcome during oncological therapy
Harvey, K. B., Bothe, A., & Blackburn, G. L. (1979) · Cancer · doi:10.1002/1097-0142(197905)43:5+ · Cited by 145
Dynamic Heterogeneity: Rapid Generation of Metastatic Variants in Mouse B16 Melanoma Cells
Hill, R. P., Chambers, A. F., Ling, V. W. T., & Harris, J. F. (1984) · Science · doi:10.1126/science.6719130 · Cited by 152
Exploiting Evolution To Treat Drug Resistance: Combination Therapy and the Double Bind
Basanta, D., Gatenby, R. A., & Anderson, A. R. A. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200458e · Cited by 151
Cell competition in development, homeostasis and cancer
van Neerven, S. M., & Vermeulen, L. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00538-y · Cited by 163
Promoter-Region Hypermethylation and Gene Silencing in Human Cancer
Herman, J. G., & Baylin, S. B. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59696-4_3 · Cited by 151
Tumor progression: a brief historical perspective
Nowell̀, P. C. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00012-3 · Cited by 155
Self-citation
Evidence for monoclonal expansion of epithelial cells in ovarian endometrial cysts.
Jimbo, H., Hitomi, Y., Yoshikawa, H., Yano, T., Momoeda, M., Sakamoto, A., Tsutsumi, O., Taketani, Y., & Esumi, H. (1997) · Europe PMC (PubMed Central) · Cited by 150
Spontaneous Fusion In Vivo Between Normal Host and Tumor Cells: Possible Contribution to Tumor Progression and Metastasis Studied with a Lectin-Resistant Mutant Tumor
Kerbel, R. S., Lagarde, A., Dennis, J. W., & Donaghue, T. P. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.4.523 · Cited by 150
p53 protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein
Poller, D. N., Roberts, E., Bell, J. A., Elston, C. W., Blamey, R. W., & Ellis, I. O. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90157-c · Cited by 150
Somatic Mosaicism in the Human Genome
Freed, D. N., Stevens, E. L., & Pevsner, J. (2014) · Genes · doi:10.3390/genes5041064 · Cited by 156
How cancer hijacks the body’s homeostasis through the neuroendocrine system
Slominski, R. M., Raman, C., Chen, J. Y., & Slominski, A. T. (2023) · Trends in Neurosciences · doi:10.1016/j.tins.2023.01.003 · Cited by 172
Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas
Czerniak, B. A., Chen, R., Tuziak, T., Markiewski, M. M., Kram, A., Gorczyca, W., Deitch, D., Herz, F., & Koss, L. G. (1989) · Cancer · doi:10.1002/1097-0142(19890515)63:10 · Cited by 18
Apoptosis: targets in pancreatic cancer.
Westphal, S., & Kalthoff, H. (2003) · Molecular Cancer · doi:10.1186/1476-4598-2-6 · Cited by 148
Colorectal Carcinogenesis: MSI‐H Versus MSI‐L
Pawlik, T. M., Raut, C. P., & Rodrı́guez-Bigas, M. A. (2004) · Disease Markers · doi:10.1155/2004/368680 · Cited by 151
Mutations, Cancer and the Telomere Length Paradox
Aviv, A., Anderson, J. J., & Shay, J. W. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.02.005 · Cited by 150
Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance
Ahmed, F., & Haass, N. K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00173 · Cited by 153
The dualistic origin of human tumors
Liu, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.004 · Cited by 148
Mechanisms of Nonneoplastic Endocrine Hyperplasia—A Changing Concept: A Review Focused on the Thyroid Gland
Studer, H., & Derwahl, M. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-411 · Cited by 148
Genomic and epigenomic heterogeneity in chronic lymphocytic leukemia
Guièze, R., & Wu, C. J. (2015) · Blood · doi:10.1182/blood-2015-02-585042 · Cited by 151
Identification of a novel gene, CDCP1, overexpressed in human colorectal cancer
Mostageer, M., Sommergruber, W., Abseher, R., Hauptmann, R., Ambros, P. F., & Schweifer, N. (2001) · Oncogene · doi:10.1038/sj.onc.1204566 · Cited by 148
The reverse evolution from multicellularity to unicellularity during carcinogenesis
Chen, H., Lin, F., Xing, K., & He, X. (2015) · Nature Communications · doi:10.1038/ncomms7367 · Cited by 155
Tracing the tumor lineage
Navin, N. E., & Hicks, J. B. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.04.010 · Cited by 152
C-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma
Burmer, G. C., Levine, D. S., Kulander, B. G., Haggitt, R. C., Rubin, C. E., & Rabinovitch, P. S. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91024-z · Cited by 144
Hormonal aspects of breast cancer
Clarke, R. C., Dickson, R. B., & Lippman, M. E. (1992) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(92)90062-u · Cited by 147
The molecular and cellular origin of human prostate cancer
Packer, J. R., & Maitland, N. J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.02.016 · Cited by 161
Inferring the Mutational History of a Tumor Using Multi-state Perfect Phylogeny Mixtures
El-Kebir, M., Satas, G., Oesper, L., & Raphael, B. J. (2016) · Cell Systems · doi:10.1016/j.cels.2016.07.004 · Cited by 150
Characterizing the ecological and evolutionary dynamics of cancer
Zahir, N., Sun, R., Gallahan, D., Gatenby, R. A., & Curtis, C. N. (2020) · Nature Genetics · doi:10.1038/s41588-020-0668-4 · Cited by 144
The Immunodominant Antigen of an Ultraviolet-induced Regressor Tumor Is Generated by a Somatic Point Mutation in the DEAD Box Helicase p68
Dubey, P., Hendrickson, R. C., Meredith, S. C., Siegel, C., Shabanowitz, J., Skipper, J., Engelhard, V. H., Hunt, D. F., & Schreiber, H. W. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.695 · Cited by 143
Tumor cell surface carbohydrate and the metastatic phenotype
Dennis, J. W., & Laferté, S. (1987) · Cancer and Metastasis Reviews · doi:10.1007/bf00046998 · Cited by 146
Single-Molecule DNA Amplification and Analysis Using Microfluidics
Zhang, C., & Xing, D. (2010) · Chemical Reviews · doi:10.1021/cr900081z · Cited by 148
Genetic instability in cancer: Theory and experiment
BECKMAN, R., & Loeb, L. A. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.007 · Cited by 145
Galectin-3 and cancer stemness
Nangia‐Makker, P., Hogan, V. A., & Raz, A. (2018) · Glycobiology · doi:10.1093/glycob/cwy001 · Cited by 147
Physical plasma-treated saline promotes an immunogenic phenotype in CT26 colon cancer cells in vitro and in vivo
Freund, E., Liedtke, K. R., van der Linde, J., Metelmann, H., Heidecke, C.-D., Partecke, L.-I., & Bekeschus, S. (2019) · Scientific Reports · doi:10.1038/s41598-018-37169-3 · Cited by 149
PyClone-VI: scalable inference of clonal population structures using whole genome data
Gillis, S., & Roth, A. J. L. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03919-2 · Cited by 145
New insights into the correlations between circulating tumor cells and target organ metastasis
Zhan, Q., Liu, B., Situ, X., Luo, Y., Fu, T., Wang, Y., Xie, Z., Ren, L., Zhu, Y. J., He, W., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01725-9 · Cited by 156
Stem cells, senescence, neosis and self-renewal in cancer.
Rajaraman, R., Guernsey, D. L., Rajaraman, M. M., & Rajaraman, S. R. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-25 · Cited by 152
Carbohydrates of the tumor cell surface
Smets, L. A., & Beek, W. P. V. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(83)90006-9 · Cited by 145
Principles of Reconstructing the Subclonal Architecture of CancersPreprint
Dentro, S. C., Wedge, D. C., & Loo, P. V. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026625 · Cited by 141
Next‐generation clinical trials: Novel strategies to address the challenge of tumor molecular heterogeneity
Catenacci, D. V. T. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.09.011 · Cited by 143
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life
Morganti, S., Tarantino, P., Ferraro, E., D’Amico, P., Viale, G., Trapani, D., Duso, B. A., & Curigliano, G. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.11.008 · Cited by 151
Chromosomal translocations: revisited yet again
Rowley, J. D. (2008) · Blood · doi:10.1182/blood-2008-04-097931 · Cited by 148
Comparison of features of human breast cancer cell lines and their corresponding tumors.
Wistuba, I. I., Behrens, C., Milchgrub, S., Syed, S., Ahmadian, M., Virmani, A. K., Kurvari, V., Cunningham, T. H., Ashfaq, R., Minna, J. D., et al. (1998) · PubMed · Cited by 143
The role of the H-ras oncogene in radiation resistance and metastasis
McKenna, W. G., Weiss, M. C., Bakanauskas, V. J., Sandler, H. M., Kelsten, M. L., Biaglow, J. E., Tuttle, S. W., Endlich, B., Ling, C. C., & Muschel, R. J. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90407-b · Cited by 145
PTH mRNA transcription analysis in infantile tumors associated with hypercalcemia
Rousseau-Merck, M.-F., Nézelof, C., de Keyzer, Y., Bourdeau, A., Cournot, G., & Mercier, F. (1988) · Cancer · doi:10.1002/1097-0142(19880715)62:2 · Cited by 14
Defective G2 checkpoint function in cells from individuals with familial cancer syndromes.
Paules, R. S., Levedakou, E. N., Wilson, S. J., Innes, C. L., Rhodes, N., Tlsty, T. D., Galloway, D. A., Donehower, L. A., Tainsky, M. A., & Kaufmann, W. K. (1995) · PubMed · Cited by 143
Reproducibility of a histopathologic grading system for adult soft tissue sarcoma
Coindre, J., Trojani, M., Contesso, G., David, M., Rouëssé, J., Nguyen, B. B., Bodaert, A., de Mascarel, I., de Mascarel, A., & Goussot, J. (1986) · Cancer · doi:10.1002/1097-0142(19860715)58:2 · Cited by 448
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas
Fack, F., Espedal, H., Keunen, O., Golebiewska, A., Obad, N., Harter, P. N., Mittelbronn, M. G. A., Bähr, O., Weyerbrock, A., Stuhr, L. E. B., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1352-5 · Cited by 146
Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma.
Blount, P. L., Meltzer, S. J., Yin, J., Huang, Y., Krasna, M. J., & Reid, B. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3221 · Cited by 143
p53 Mutations in Barrett's adenocarcinoma and high-grade dysplasia
Neshat, K., Sanchez, C. A., Galipeau, P. C., Blount, P. L., Levine, D. S., Joslyn, G., & Reid, B. J. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90415-4 · Cited by 143
myc oncogenes: activation and amplification
Alitalo, K. K., Koskinen, P. J., Mäkelä, T. P., Saksela, K., Sistonen, L., & Winqvist, R. (1987) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(87)90016-3 · Cited by 138
Multistep skin cancer in mice as a model to study the evolution of cancer cells
Kemp, C. J. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.06.003 · Cited by 144
Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions
Lee, J., Lee, J., Farquhar, K. S., Yun, J., Frankenberger, C. A., Bevilacqua, E., Yeung, K. C., Kim, E., Balázsi, G., & Rosner, M. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304840111 · Cited by 141
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance
Saha, T., & Lukong, K. E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.856974 · Cited by 148
Genomic mechanisms and measurement of structural and numerical instability in cancer cells
Bayani, J., Selvarajah, S., Maire, G., Vukovic, B., Al-Romaih, K. I., Zieleńska, M., & Squire, J. A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.10.006 · Cited by 144
Advanced Materials for Co‐Delivery of Drugs and Genes in Cancer Therapy
Khan, M., Ong, Z. Y., Wiradharma, N., Attia, A. B. E., & Yang, Y. Y. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200109 · Cited by 142
Emerging roles of intratumor microbiota in cancer metastasis
Fu, A., Yao, B., Dong, T., & Cai, S. (2022) · Trends in Cell Biology · doi:10.1016/j.tcb.2022.11.007 · Cited by 146
Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression
Mussman, J. G., Horn, H. F., Carroll, P. E., Okuda, M., Tarapore, P., Donehower, L. A., & Fukasawa, K. (2000) · Oncogene · doi:10.1038/sj.onc.1203460 · Cited by 142
The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
Zeng, S. S., Yamashita, T., Kondo, M., Nio, K., Hayashi, T., Hara, Y., Nomura, Y., Yoshida, M., Hayashi, T., Oishi, N., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.024 · Cited by 140
Tumor heterogeneity and cancer stem cell paradigm: Updates in concept, controversies and clinical relevance
Singh, A. K., Arya, R. K., Maheshwari, S., Singh, A., Meena, S., Pandey, P., Dormond, O., & Datta, D. B. (2014) · International Journal of Cancer · doi:10.1002/ijc.28804 · Cited by 145
The roles of telomeres and telomerase in cell life span
Counter, C. M. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90006-8 · Cited by 139
Gold from the sea: Marine compounds as inhibitors of the hallmarks of cancer
Schumacher, M., Kelkel, M., Dicato, M., & Diederich, M. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.02.002 · Cited by 138
Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation
Sung, M., Wang, M., MacLennan, G. T., Eble, J. N., Tan, P., Antonio Lopez-beltran, B., Montironi, R., Harris, J., Kuhar, M., & Cheng, L. (2007) · The Journal of Pathology · doi:10.1002/path.2129 · Cited by 137

Authors: Nowell, P. C.
Affiliations: School of Medicine, University of Pennsylvania, Philadelphia 19174.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 1976-10
Volume: 194
Issue: 4260
Pages: 23-28
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.959840
OpenAlex: W1967304777
Cited by: 6,471
References: 52
Citations by year: 2026: 117 · 2025: 163 · 2024: 183 · 2023: 201 · 2022: 209 · 2021: 282 · 2020: 287 · 2019: 259 · 2018: 304 · 2017: 332 · 2016: 263 · 2015: 261 · 2014: 241 · 2013: 233 · 2012: 200
FWCI: 16.73
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords: clonal evolution, tumor progression, karyotypic heterogeneity, tumor cell populations, treatment resistance, carcinogen exposure, precision oncology
MeSH terms: Carcinogens, Chromosomes, Clone Cells, Karyotyping, Models, Biological, Mutation, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks